Frazier Life Sciences XI, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001911592. 10% Owner at Attovia Therapeutics, Inc. (ATTO). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in PALO ALTO, CA.
Companies Frazier Life Sciences XI, L.P. has filed insider reports for
- Attovia Therapeutics, Inc. (ATTO): 10% Owner
Frazier Life Sciences XI, L.P.
CIK: 0001911592
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)4 (80.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATTO
Attovia Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionDirect1.7M shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionDirect1.6M shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionDirect1.2M shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionDirect961.3K shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
PurchaseDirect588.2K shares at avg. $17.00$10.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 1,749,192 | - | $0 | Direct |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 1,590,175 | - | $0 | Direct |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 1,189,940 | - | $0 | Direct |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 961,322 | - | $0 | Direct |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Purchase | 588,235 | $17.00 | $9,999,995 | Direct |
1-5 of 5 transactions